Henry Ward Wolff Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Henry Ward Wolff.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Henry Ward Wolff. Henry Ward Wolff is CFO & SVP, Finance in ABGENIX INC ($ABGX) and CFO and Sr. VP, Finance in ABGENIX INC ($ABGX) and Exec VP & CFO in SANGAMO BIOSCIENCES INC ($SGMO) and Director in SUNESIS PHARMACEUTICALS INC ($SNSS) and Director in PORTOLA PHARMACEUTICALS INC ($PTLA) and Director in Calithera Biosciences, Inc. ($CALA).
Latest Insider Trading Transactions of Henry Ward Wolff
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, ABGX, CALA, PTLA, SGMO, SNSS
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jul 02 2020 | PTLA | PORTOLA PHARMACEUT ... | Wolff Henry Ward | Director | Option Exercise | D | 17.94 | 11,377 | 204,103 | 0 | |
Jul 02 2020 | PTLA | PORTOLA PHARMACEUT ... | Wolff Henry Ward | Director | Option Exercise | D | 7.00 | 5,000 | 35,000 | 0 | |
Jul 02 2020 | PTLA | PORTOLA PHARMACEUT ... | Wolff Henry Ward | Director | Option Exercise | D | 7.00 | 5,520 | 38,640 | 0 | |
Jul 02 2020 | PTLA | PORTOLA PHARMACEUT ... | Wolff Henry Ward | Director | Option Exercise | D | 0.00 | 59,092 | 0 | 0 | |
Jul 02 2020 | PTLA | PORTOLA PHARMACEUT ... | Wolff Henry Ward | Director | Sell | D | 18.00 | 7,281 | 131,058 | 0 | 7.3 K to 0 (-100.00 %) |
Jul 02 2020 | PTLA | PORTOLA PHARMACEUT ... | Wolff Henry Ward | Director | Sell | D | 18.00 | 17,960 | 323,280 | 0 | 18 K to 0 (-100.00 %) |
Jul 01 2020 | SNSS | SUNESIS PHARMACEUT ... | Wolff Henry Ward | Director | Option Exercise | A | 0.26 | 60,000 | 15,804 | 60,000 | |
Jun 15 2020 | PTLA | PORTOLA PHARMACEUT ... | Wolff Henry Ward | Director | Option Exercise | A | 17.94 | 11,377 | 204,103 | 11,377 | |
Jun 15 2020 | PTLA | PORTOLA PHARMACEUT ... | Wolff Henry Ward | Director | Grant | A | 0.00 | 7,281 | 0 | 25,241 | 18 K to 25.2 K (+40.54 %) |
Jun 11 2020 | CALA | Calithera Bioscien ... | Wolff Henry Ward | Director | Option Exercise | A | 5.25 | 20,000 | 105,000 | 20,000 | |
Jul 02 2019 | SNSS | SUNESIS PHARMACEUT ... | Wolff Henry Ward | Director | Option Exercise | A | 0.73 | 60,000 | 43,608 | 60,000 | |
Jun 17 2019 | PTLA | PORTOLA PHARMACEUT ... | Wolff Henry Ward | Director | Option Exercise | A | 26.09 | 6,991 | 182,395 | 6,991 | |
Jun 17 2019 | PTLA | PORTOLA PHARMACEUT ... | Wolff Henry Ward | Director | Grant | A | 0.00 | 4,194 | 0 | 17,960 | 13.8 K to 18 K (+30.47 %) |
Jun 05 2019 | PTLA | PORTOLA PHARMACEUT ... | Wolff Henry Ward | Director | Sell | M | 27.55 | 2,000 | 55,104 | 0 | 2 K to 0 (-100.00 %) |
Jun 03 2019 | CALA | Calithera Bioscien ... | Wolff Henry Ward | Director | Option Exercise | A | 5.42 | 11,000 | 59,620 | 11,000 | |
Mar 14 2019 | PTLA | PORTOLA PHARMACEUT ... | Wolff Henry Ward | Director | Option Exercise | M | 5.10 | 5,000 | 25,500 | 0 | |
Mar 14 2019 | PTLA | PORTOLA PHARMACEUT ... | Wolff Henry Ward | Director | Buy | M | 5.10 | 5,000 | 25,500 | 15,766 | 10.8 K to 15.8 K (+46.44 %) |
Jul 03 2018 | SNSS | SUNESIS PHARMACEUT ... | Wolff Henry Ward | Director | Option Exercise | A | 2.12 | 6,250 | 13,250 | 6,250 | |
Jul 03 2018 | SNSS | SUNESIS PHARMACEUT ... | Wolff Henry Ward | Director | Option Exercise | A | 6.80 | 37,500 | 255,000 | 37,500 | |
Jun 08 2018 | PTLA | PORTOLA PHARMACEUT ... | Wolff Henry Ward | Director | Option Exercise | A | 42.81 | 6,000 | 256,860 | 6,000 | |
Jun 08 2018 | PTLA | PORTOLA PHARMACEUT ... | Wolff Henry Ward | Director | Grant | A | 0.00 | 3,000 | 0 | 10,766 | 7.8 K to 10.8 K (+38.63 %) |
Jun 04 2018 | CALA | Calithera Bioscien ... | Wolff Henry Ward | Director | Option Exercise | A | 5.15 | 11,000 | 56,650 | 11,000 | |
Dec 18 2017 | PTLA | PORTOLA PHARMACEUT ... | Wolff Henry Ward | Director | Option Exercise | M | 5.30 | 12,000 | 63,600 | 0 | |
Dec 18 2017 | PTLA | PORTOLA PHARMACEUT ... | Wolff Henry Ward | Director | Sell | S | 47.77 | 700 | 33,438 | 0 | 700 to 0 (-100.00 %) |
Dec 18 2017 | PTLA | PORTOLA PHARMACEUT ... | Wolff Henry Ward | Director | Sell | S | 46.95 | 11,300 | 530,512 | 700 | 12 K to 700 (-94.17 %) |
Dec 18 2017 | PTLA | PORTOLA PHARMACEUT ... | Wolff Henry Ward | Director | Buy | M | 5.30 | 12,000 | 63,600 | 12,000 | 0 to 12 K |
Oct 06 2017 | PTLA | PORTOLA PHARMACEUT ... | Wolff Henry Ward | Director | Option Exercise | M | 5.30 | 12,000 | 63,600 | 0 | |
Oct 06 2017 | PTLA | PORTOLA PHARMACEUT ... | Wolff Henry Ward | Director | Buy | M | 5.30 | 12,000 | 63,600 | 12,000 | 0 to 12 K |
Jun 19 2017 | PTLA | PORTOLA PHARMACEUT ... | Wolff Henry Ward | Director | Option Exercise | A | 35.06 | 6,000 | 210,360 | 6,000 | |
Jun 19 2017 | PTLA | PORTOLA PHARMACEUT ... | Wolff Henry Ward | Director | Grant | A | 0.00 | 3,000 | 0 | 3,000 | 0 to 3 K |
Jun 13 2017 | CALA | Calithera Bioscien ... | Wolff Henry Ward | Director | Option Exercise | A | 14.20 | 11,000 | 156,200 | 11,000 | |
Dec 14 2016 | SGMO | SANGAMO BIOSCIENCE ... | Wolff Henry Ward | Exec VP & CFO | Payment of Exercise | F | 3.05 | 13,778 | 42,023 | 206,829 | 220.6 K to 206.8 K (-6.25 %) |
Jun 16 2016 | CALA | Calithera Bioscien ... | Wolff Henry Ward | Director | Option Exercise | A | 4.76 | 11,000 | 52,360 | 11,000 | |
Dec 15 2015 | SGMO | SANGAMO BIOSCIENCE ... | Wolff Henry Ward | Exec VP & CFO | Payment of Exercise | F | 8.68 | 6,087 | 52,835 | 215,703 | 221.8 K to 215.7 K (-2.74 %) |
Dec 15 2015 | SGMO | SANGAMO BIOSCIENCE ... | Wolff Henry Ward | Exec VP & CFO | Payment of Exercise | F | 8.68 | 6,522 | 56,611 | 221,790 | 228.3 K to 221.8 K (-2.86 %) |
Dec 09 2015 | SGMO | SANGAMO BIOSCIENCE ... | Wolff Henry Ward | Exec VP & CFO | Option Exercise | A | 9.41 | 75,000 | 705,750 | 75,000 | |
Dec 09 2015 | SGMO | SANGAMO BIOSCIENCE ... | Wolff Henry Ward | Exec VP & CFO | Payment of Exercise | F | 9.69 | 7,060 | 68,411 | 228,312 | 235.4 K to 228.3 K (-3.00 %) |
Dec 09 2015 | SGMO | SANGAMO BIOSCIENCE ... | Wolff Henry Ward | Exec VP & CFO | Grant | A | 0.00 | 37,500 | 0 | 235,372 | 197.9 K to 235.4 K (+18.95 %) |
Jul 14 2015 | SGMO | SANGAMO BIOSCIENCE ... | Wolff Henry Ward | Exec VP & CFO | Option Exercise | M | 3.45 | 3,898 | 13,448 | 112,000 | |
Jul 14 2015 | SGMO | SANGAMO BIOSCIENCE ... | Wolff Henry Ward | Exec VP & CFO | Option Exercise | M | 3.45 | 6,102 | 21,052 | 115,898 | |
Jul 14 2015 | SGMO | SANGAMO BIOSCIENCE ... | Wolff Henry Ward | Exec VP & CFO | Sell | S | 10.00 | 2,000 | 20,000 | 197,872 | 199.9 K to 197.9 K (-1.00 %) |
Jul 14 2015 | SGMO | SANGAMO BIOSCIENCE ... | Wolff Henry Ward | Exec VP & CFO | Sell | S | 10.00 | 3,898 | 38,980 | 199,872 | 203.8 K to 199.9 K (-1.91 %) |
Jul 14 2015 | SGMO | SANGAMO BIOSCIENCE ... | Wolff Henry Ward | Exec VP & CFO | Buy | M | 3.45 | 3,898 | 13,448 | 203,770 | 199.9 K to 203.8 K (+1.95 %) |
Jul 14 2015 | SGMO | SANGAMO BIOSCIENCE ... | Wolff Henry Ward | Exec VP & CFO | Sell | S | 10.00 | 6,102 | 61,020 | 199,872 | 206 K to 199.9 K (-2.96 %) |
Jul 14 2015 | SGMO | SANGAMO BIOSCIENCE ... | Wolff Henry Ward | Exec VP & CFO | Buy | M | 3.45 | 6,102 | 21,052 | 205,974 | 199.9 K to 206 K (+3.05 %) |
Jun 17 2015 | PTLA | PORTOLA PHARMACEUT ... | Wolff Henry Ward | Director | Option Exercise | A | 44.39 | 10,000 | 443,900 | 10,000 | |
Jun 12 2015 | SGMO | SANGAMO BIOSCIENCE ... | Wolff Henry Ward | Exec VP & CFO | Option Exercise | M | 3.45 | 10,000 | 34,500 | 122,000 | |
Jun 12 2015 | SGMO | SANGAMO BIOSCIENCE ... | Wolff Henry Ward | Exec VP & CFO | Sell | S | 12.21 | 2,000 | 24,423 | 199,872 | 201.9 K to 199.9 K (-0.99 %) |
Jun 12 2015 | SGMO | SANGAMO BIOSCIENCE ... | Wolff Henry Ward | Exec VP & CFO | Sell | S | 12.21 | 10,000 | 122,135 | 201,872 | 211.9 K to 201.9 K (-4.72 %) |
Jun 12 2015 | SGMO | SANGAMO BIOSCIENCE ... | Wolff Henry Ward | Exec VP & CFO | Buy | M | 3.45 | 10,000 | 34,500 | 211,872 | 201.9 K to 211.9 K (+4.95 %) |
Jun 11 2015 | CALA | Calithera Bioscien ... | Wolff Henry Ward | Director | Option Exercise | A | 7.99 | 11,000 | 87,890 | 33,000 | |
May 13 2015 | SGMO | SANGAMO BIOSCIENCE ... | Wolff Henry Ward | Exec VP & CFO | Option Exercise | M | 3.45 | 10,000 | 34,500 | 132,000 | |
May 13 2015 | SGMO | SANGAMO BIOSCIENCE ... | Wolff Henry Ward | Exec VP & CFO | Sell | S | 13.25 | 2,000 | 26,493 | 201,872 | 203.9 K to 201.9 K (-0.98 %) |
May 13 2015 | SGMO | SANGAMO BIOSCIENCE ... | Wolff Henry Ward | Exec VP & CFO | Sell | S | 13.25 | 10,000 | 132,456 | 203,872 | 213.9 K to 203.9 K (-4.68 %) |
May 13 2015 | SGMO | SANGAMO BIOSCIENCE ... | Wolff Henry Ward | Exec VP & CFO | Buy | M | 3.45 | 10,000 | 34,500 | 213,872 | 203.9 K to 213.9 K (+4.91 %) |
Apr 14 2015 | SGMO | SANGAMO BIOSCIENCE ... | Wolff Henry Ward | Exec VP & CFO | Option Exercise | M | 3.45 | 10,000 | 34,500 | 142,000 | |
Apr 14 2015 | SGMO | SANGAMO BIOSCIENCE ... | Wolff Henry Ward | Exec VP & CFO | Sell | S | 15.37 | 1,029 | 15,813 | 202,849 | 203.9 K to 202.8 K (-0.50 %) |
Apr 14 2015 | SGMO | SANGAMO BIOSCIENCE ... | Wolff Henry Ward | Exec VP & CFO | Sell | S | 15.43 | 971 | 14,984 | 203,878 | 204.8 K to 203.9 K (-0.47 %) |
Apr 14 2015 | SGMO | SANGAMO BIOSCIENCE ... | Wolff Henry Ward | Exec VP & CFO | Sell | S | 15.30 | 10,000 | 152,974 | 204,849 | 214.8 K to 204.8 K (-4.65 %) |
Apr 14 2015 | SGMO | SANGAMO BIOSCIENCE ... | Wolff Henry Ward | Exec VP & CFO | Buy | M | 3.45 | 10,000 | 34,500 | 214,849 | 204.8 K to 214.8 K (+4.88 %) |
Mar 20 2015 | SGMO | SANGAMO BIOSCIENCE ... | Wolff Henry Ward | Exec VP & CFO | Option Exercise | M | 14.27 | 10,000 | 142,700 | 251,972 | |
Mar 20 2015 | SGMO | SANGAMO BIOSCIENCE ... | Wolff Henry Ward | Exec VP & CFO | Sell | S | 18.00 | 10,000 | 180,000 | 204,849 | 214.8 K to 204.8 K (-4.65 %) |
Mar 20 2015 | SGMO | SANGAMO BIOSCIENCE ... | Wolff Henry Ward | Exec VP & CFO | Buy | M | 14.27 | 10,000 | 142,700 | 214,849 | 204.8 K to 214.8 K (+4.88 %) |
Mar 12 2015 | SGMO | SANGAMO BIOSCIENCE ... | Wolff Henry Ward | Exec VP & CFO | Option Exercise | M | 3.45 | 10,000 | 34,500 | 152,000 | |
Mar 12 2015 | SGMO | SANGAMO BIOSCIENCE ... | Wolff Henry Ward | Exec VP & CFO | Sell | S | 16.68 | 2,000 | 33,365 | 204,849 | 206.8 K to 204.8 K (-0.97 %) |
Mar 12 2015 | SGMO | SANGAMO BIOSCIENCE ... | Wolff Henry Ward | Exec VP & CFO | Sell | S | 16.68 | 10,000 | 166,836 | 206,849 | 216.8 K to 206.8 K (-4.61 %) |
Mar 12 2015 | SGMO | SANGAMO BIOSCIENCE ... | Wolff Henry Ward | Exec VP & CFO | Buy | M | 3.45 | 10,000 | 34,500 | 216,849 | 206.8 K to 216.8 K (+4.83 %) |
Mar 06 2015 | SGMO | SANGAMO BIOSCIENCE ... | Wolff Henry Ward | Exec VP & CFO | Option Exercise | M | 14.27 | 10,000 | 142,700 | 261,972 | |
Mar 06 2015 | SGMO | SANGAMO BIOSCIENCE ... | Wolff Henry Ward | Exec VP & CFO | Sell | S | 18.00 | 10,000 | 180,000 | 206,849 | 216.8 K to 206.8 K (-4.61 %) |
Mar 06 2015 | SGMO | SANGAMO BIOSCIENCE ... | Wolff Henry Ward | Exec VP & CFO | Buy | M | 14.27 | 10,000 | 142,700 | 216,849 | 206.8 K to 216.8 K (+4.83 %) |
Apr 04 2006 | ABGX | ABGENIX INC | Wolff Henry Ward | CFO & SVP, Finance | Option Exercise | D | 8.98 | 4,418 | 39,674 | 0 | |
Apr 04 2006 | ABGX | ABGENIX INC | Wolff Henry Ward | CFO & SVP, Finance | Option Exercise | D | 8.98 | 31,682 | 284,504 | 0 | |
Apr 04 2006 | ABGX | ABGENIX INC | Wolff Henry Ward | CFO & SVP, Finance | Option Exercise | D | 10.91 | 166,400 | 1,815,424 | 0 | |
Apr 04 2006 | ABGX | ABGENIX INC | Wolff Henry Ward | CFO & SVP, Finance | Sell | D | 22.50 | 24,994 | 562,365 | 0 | 25 K to 0 (-100.00 %) |
Mar 28 2006 | ABGX | ABGENIX INC | Wolff Henry Ward | CFO & SVP, Finance | Option Exercise | M | 10.91 | 8,600 | 93,826 | 166,400 | |
Mar 28 2006 | ABGX | ABGENIX INC | Wolff Henry Ward | CFO & SVP, Finance | Option Exercise | M | 8.98 | 13,900 | 124,822 | 31,682 | |
Mar 28 2006 | ABGX | ABGENIX INC | Wolff Henry Ward | CFO & SVP, Finance | Buy | M | 10.91 | 8,600 | 93,826 | 24,994 | 16.4 K to 25 K (+52.46 %) |
Mar 28 2006 | ABGX | ABGENIX INC | Wolff Henry Ward | CFO & SVP, Finance | Buy | M | 8.98 | 13,900 | 124,822 | 16,394 | 2.5 K to 16.4 K (+557.34 %) |
Jan 21 2005 | ABGX | ABGENIX INC | Wolff Henry Ward | CFO and Sr. VP, Fin ... | Option Exercise | A | 8.98 | 4,418 | 39,674 | 4,418 | |
Jan 21 2005 | ABGX | ABGENIX INC | Wolff Henry Ward | CFO and Sr. VP, Fin ... | Option Exercise | A | 8.98 | 45,582 | 409,326 | 45,582 |
Page: 1